Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05961332 · ClinicalTrials.gov registry record · NA
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT05961332: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT05961332 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05961332, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will be patients of a retina doctor at University Station Eye Clinic with geographic atrophy, and can expect to be in the study for 60-75 minutes.
Primary Outcome
Graders will independently measure area of GA from images of each device. The measurements (in mm²) will be compared between the devices.
Interventions
- DEVICE Spectralis FAF imaging
- DEVICE Optos imaging
- DEVICE Zeiss Clarus 700 imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
What the finished NCT05961332 record still lists
NCT05961332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Spectralis FAF imaging is the first listed.
NCT05961332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05961332 about?
NCT05961332 is a clinical study titled "COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy". The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will...
What is the current status of trial NCT05961332?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2023-10-06. Estimated completion is 2025-05-27.
What interventions are being tested in trial NCT05961332?
The interventions under investigation include: Spectralis FAF imaging (DEVICE), Optos imaging (DEVICE), Zeiss Clarus 700 imaging (DEVICE).
Who is sponsoring clinical trial NCT05961332?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05961332's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI